Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications-Reference-Cited by-同舟云学术

Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications

Published:2008-09-30 Issue:19 Volume:14 Page:6033-6041
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Leone Paola E.,Walker Brian A.,Jenner Matthew W.,Chiecchio Laura,Dagrada GianPaolo,Protheroe Rebecca K.M.,Johnson David C.,Dickens Nicholas J.,Brito Jose Luis,Else Monica,Gonzalez David,Ross Fiona M.,Chen-Kiang Selina,Davies Faith E.,Morgan Gareth J.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA?;Mediterranean Journal of Hematology and Infectious Diseases;2024-04-30

2. TRIM33 loss in multiple myeloma is associated with genomic instability and sensitivity to PARP inhibitors;Scientific Reports;2024-04-16

3. Section E6.1–6.6 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in neoplastic blood, bone marrow, and lymph nodes;Genetics in Medicine;2024-04

4. Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma;Clinical Cancer Research;2023-07-14

5. Pathogenesis, clinical characteristics and personalized managements of multiple myeloma with chromosome 1 abnormalities;Leukemia & Lymphoma;2023-06-10